UK markets open in 4 hours 30 minutes
  • NIKKEI 225

    30,500.05
    +176.75 (+0.58%)
     
  • HANG SENG

    24,102.64
    -818.12 (-3.28%)
     
  • CRUDE OIL

    71.42
    -0.55 (-0.76%)
     
  • GOLD FUTURES

    1,748.90
    -2.50 (-0.14%)
     
  • DOW

    34,584.88
    -166.42 (-0.48%)
     
  • BTC-GBP

    34,286.21
    -892.45 (-2.54%)
     
  • CMC Crypto 200

    1,173.23
    -52.30 (-4.27%)
     
  • ^IXIC

    15,043.97
    -137.93 (-0.91%)
     
  • ^FTAS

    4,023.33
    -28.11 (-0.69%)
     

CompuGroup Medical acquires VISUS Health IT

  • Oops!
    Something went wrong.
    Please try again later.
·4-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Mergers & Acquisitions
01.06.2021 / 15:16
The issuer is solely responsible for the content of this announcement.


Koblenz. CompuGroup Medical SE & Co. KGaA (CGM), one of the leading e-health companies in the world, acquired VISUS Health IT GmbH (VISUS), one of the leading providers for Picture Archiving and Communication Systems (PACS) and Healthcare Content Management in Germany. 

VISUS's key products are JiveX Enterprise PACS, a leading PACS for hospitals and outpatient facilities, JiveX Healthcare Content Management, a cutting-edge vendor neutral archive solution for medical data, and JiveX Healthcare Connect with focus on communicating medical data. As a result of the acquisition, CompuGroup Medical is complementing its portfolio with a well-established and multiple award-winning product suite. For 2020, revenues were amounted to approximately EUR 18.5 million with an adjusted EBITDA of approximately EUR 2.8 million.                                                                                                    

"VISUS complements our existing portfolio of products perfectly and we see a lot of opportunities to integrate these solutions with our successful ambulatory and hospital information systems," emphasized Dr. Dirk Wössner, CEO of CompuGroup Medical SE & Co. KGaA. "We are confident that both, existing CGM and VISUS customers, will benefit from this transaction, facilitating the provision of structured medical data at the right place and time and usable by anyone who needs it. VISUS solutions are a key contributor of medical information with the special focus on medical images."

"With this acquisition, we will gain an additional, highly attractive business area, which is very important for most of our customers, and we will significantly increase our installed customer base particularly in the German hospital market. At the same time, we will benefit from a great amount of know-how and expert knowledge from our new colleagues. We are acquiring innovative and strongly growing products here, which have recently been repeatedly honored with several highly prestigious 'Best in KLAS-Awards'," said Hannes Reichl, Managing Director Inpatient and Social Care at CGM.

"We are convinced that with this merger we will continue the success story of VISUS for our team and our customers in the long term. With CGM, we also have the potential to further expand our existing partner network internationally," said Klaus Kleber, Co-Founder of VISUS. Jörg Holstein, likewise Co-Founder of VISUS, added, "We have been partners with CGM for many years and have implemented many successful projects together. We are pleased to become part of the CGM family while maintaining the VISUS identity. CGM is exactly the right partner for us as a global player with home and heart in Germany."

VISUS's customer base today consists of more than 1.500 facilities inpatient as well as outpatient. Today, more than 1.6 million professional users, including doctors, dentists, pharmacies and other health professionals in outpatient and inpatient healthcare facilities trust CompuGroup Medical.




About CompuGroup Medical SE & Co. KGaA
CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 837 million in 2020, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. Approximately 8,000 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.


Contact for media representatives:
Michael Franz
Head of Brand Communication
P +49 (0) 261 8000-6100
F +49 (0) 261 8000-3100
E-mail: press@cgm.com


Contact for analysts and investors:
Claudia Thomé
Corporate Vice President Investor Relations
P +49 (0) 261 8000-7030
F +49 (0) 261 8000-3200
E-mail: claudia.thome@cgm.com
 


01.06.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:

English

Company:

CompuGroup Medical SE & Co. KGaA

Maria Trost 21

56070 Koblenz

Germany

Phone:

+49 (0)261 8000 7030

Fax:

+49 (0)261 8000 3200

E-mail:

investor@cgm.com

Internet:

www.cgm.com

ISIN:

DE000A288904

WKN:

A28890

Indices:

MDAX, TecDAX

Listed:

Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange

EQS News ID:

1203209


 

End of News

DGAP News Service

show this
show this
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting